Lumea, a leader in digital pathology solutions, has chosen Tempus, a leader in artificial intelligence and precision medicine, to create AI-enabled solutions LEHI, UTAH, UNITED STATES, August 4, 2022 — Lumea…
Read More
An ancillary or molecular test is a medical test for a patient that is not a part of the original study design. There are a wide variety of ancillary tests…
LEHI, UTAH, USA — June 1, 2022 — Lumea Inc, a global leader in integrated digital pathology solutions, is pleased to announce the first-of-its-kind Digital Diagnostic Summit in Park City,…
Lumea, a global leader in integrated digital pathology solutions, is pleased to announce the first-of-its-kind Digital Diagnostic Summit in Park City, Utah. Today, Lumea announces the presenters for the 2022...
Read More
BioVantra is an early adopter of digital pathology. Digital pathology is digitizing glass slides using a whole slide image scanner and then analyzing the digital images using an image viewer,…
Following in the footsteps of radiology, its brother in imaging analysis arms, digital pathology has recently become a popular canvas for artificial intelligence applications. Startups like Ibex, previous Fierce 15…
